These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Nevada
|
26-2797630
|
|
|
(State or jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification Number)
|
|
|
6460 Medical Center St. Suite 230
Las Vegas, NV
|
89148
|
|
|
(Address of principal executive offices)
|
(Zip code)
|
|
Large Accelerated Filer
|
£
|
Accelerated Filer
|
£
|
|
Non-Accelerated Filer
|
£
|
Smaller Reporting Company
|
T
|
|
Page
|
|
|
3
|
|
| 8 | |
|
11
|
|
|
12
|
|
|
13
|
|
|
13
|
|
|
13
|
|
|
13
|
|
|
13
|
|
|
14
|
|
|
14
|
|
|
15
|
|
|
As of
|
As of
|
||||||
|
June 30,
|
December 31,
|
|||||||
|
2013
|
2012
|
|||||||
|
(Unaudited)
|
(Audited)
|
|||||||
| ASSETS | ||||||||
|
CURRENT ASSETS
|
||||||||
|
Cash
|
$ | 1,222 | $ | 5,523 | ||||
|
Accounts receivable
|
47,673 | 27,406 | ||||||
|
Prepaid expenses
|
- | 254,600 | ||||||
|
Inventory
|
15,825 | 11,846 | ||||||
|
Total current assets
|
64,720 | 299,375 | ||||||
|
Property and Equipment, Net
|
193,416 | 129,063 | ||||||
|
Total assets
|
258,136 | 428,438 | ||||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 306,187 | $ | 28,188 | ||||
|
10% Series A Senior (non-subordinated) debentures
|
5,000 | 10,000 | ||||||
|
Accrued interest
|
11,638 | 11,183 | ||||||
|
Loan payable
|
110,000 | 25,000 | ||||||
|
Total current liabilities
|
432,825 | 74,371 | ||||||
|
Total liabilities
|
432,825 | 74,371 | ||||||
|
STOCKHOLDERS' DEFICIT
|
||||||||
|
Common stock: $0.001 par value; 300,000,000 authorized, 193,856,138 and 161,303,196 shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively
|
193,856 | 161,303 | ||||||
|
Additional paid-in capital - common stock
|
9,180,107 | 8,115,743 | ||||||
|
Preferred stock: $1.00 par value; 500,000 authorized, 40,500 and 37,500 shares issued and outstanding as of June 30, 2013 and December 31, 2012
|
41 | 38 | ||||||
|
Additional paid in capital - preferred stock
|
40,460 | 37,462 | ||||||
|
Net assets from discontinued operations
|
- | 15,633 | ||||||
|
Accumulated deficit
|
(9,589,153 | ) | (7,976,112 | ) | ||||
|
Total stockholders' equity (deficit)
|
(174,689 | ) | 354,067 | |||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT
|
$ | 258,136 | $ | 428,438 | ||||
|
For the Three Months Ended
|
For the Six Months Ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
June 30,
|
June 30,
|
|||||||||||||
|
2013
|
2012
|
2013
|
2012
|
|||||||||||||
|
REVENUES
|
$ | 98,897 | $ | 118,774 | $ | 213,194 | $ | 252,187 | ||||||||
|
Cost of goods sold
|
43,619 | 37,608 | 54,002 | 75,528 | ||||||||||||
|
Gross Profit
|
55,278 | 81,166 | 159,192 | 176,659 | ||||||||||||
|
General, selling and administrative expenses
|
674,120 | 736,012 | 1,740,811 | 1,297,923 | ||||||||||||
|
Depreciation
|
12,764 | 10,145 | 22,947 | 20,290 | ||||||||||||
|
Total operating expenses
|
686,884 | 746,157 | 1,763,758 | 1,318,213 | ||||||||||||
|
Operating Loss
|
(631,606 | ) | (664,991 | ) | (1,604,566 | ) | (1,141,554 | ) | ||||||||
|
Other income (expense):
|
||||||||||||||||
|
Other income
|
- | - | - | 10,200 | ||||||||||||
|
Interest expense
|
(7,389 | ) | (1,037 | ) | (8,475 | ) | (2,539 | ) | ||||||||
|
Total other (expenses)
|
(7,389 | ) | (1,037 | ) | (8,475 | ) | 7,661 | |||||||||
|
Net Loss
|
(638,995 | ) | (666,028 | ) | (1,613,041 | ) | (1,133,893 | ) | ||||||||
|
Net loss per common share - basic and diluted
|
$ | (0.00 | ) | $ | (0.01 | ) | $ | (0.01 | ) | $ | (0.01 | ) | ||||
|
Weighted average of common shares outstanding
|
191,514,873 | 126,032,314 | 181,099,862 | 121,580,518 | ||||||||||||
|
For the Six Months Ended
|
||||||||
|
June 30,
|
June 30,
|
|||||||
|
2013
|
2012
|
|||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net Loss
|
$ | (1,613,041 | ) | $ | (1,133,893 | ) | ||
|
Depreciation
|
12,764 | 32,175 | ||||||
|
Common stock issued for services
|
1,096,917 | 1,153,994 | ||||||
|
Net assets from discontinued operations
|
(15,633 | ) | - | |||||
|
Changes in assets and liabilities:
|
||||||||
|
Decrease(Increase) accounts receivable
|
(20,267 | ) | (112,188 | ) | ||||
|
Decrease(Increase) prepaid expense
|
254,600 | 4,999 | ||||||
|
Decrease(Increase) inventory
|
(3,979 | ) | 20,780 | |||||
|
Increase (decrease) accounts payable and accrued expenses
|
277,999 | 21,983 | ||||||
|
Due to Bio Multimin
|
- | (248 | ) | |||||
|
Net cash used in operating activities
|
(10,640 | ) | (12,398 | ) | ||||
|
Cash flows used in Investing Activities:
|
||||||||
|
Acquisition of property equipment
|
(77,117 | ) | (13,185 | ) | ||||
|
Net cash used in investing activities
|
(77,117 | ) | (13,185 | ) | ||||
|
Cash flows from Financing Activities:
|
||||||||
|
Accrued interest
|
455 | 2,512 | ||||||
|
Proceeds from loan
|
85,000 | - | ||||||
|
Repayment of debentures
|
(5,000 | ) | - | |||||
|
Preferred stock issued for cash
|
3,001 | - | ||||||
|
Common stock issued for cash
|
- | 12,000 | ||||||
|
Net cash provided by financing activities
|
83,456 | 14,512 | ||||||
|
Net increase (decrease) in cash
|
(4,301 | ) | (11,071 | ) | ||||
|
Cash, beginning of period
|
5,523 | 12,555 | ||||||
|
Cash, end of period
|
$ | 1,222 | $ | 1,484 | ||||
|
Cash paid for interest
|
$ | 1,085 | $ | 2,539 | ||||
|
Supplemental schedule of non-cash activities:
|
||||||||
|
Common stock issued for services
|
$ | 1,096,917 | $ | 1,153,994 | ||||
|
June 30,
|
June 30,
|
$ | % | |||||||||||||
|
2013
|
2012
|
Change
|
Change
|
|||||||||||||
|
REVENUES
|
$ | 98,897 | $ | 118,774 | $ | (19,877 | ) | -17 | % | |||||||
|
Cost of sales
|
43,619 | 37,608 | 6,011 | 16 | % | |||||||||||
| 55,278 | 81,166 | (25,888 | ) | |||||||||||||
|
General and administrative expenses
|
674,120 | 736,012 | (61,892 | ) | -8 | % | ||||||||||
|
Operating Loss
|
$ | (618,842 | ) | $ | (654,846 | ) | $ | 36,004 | ||||||||
|
June 30,
|
June 30,
|
$ | % | |||||||||||||
|
2013
|
2012
|
Change
|
Change
|
|||||||||||||
|
REVENUES
|
$ | 213,194 | $ | 252,187 | $ | (38,993 | ) | -15 | % | |||||||
|
Cost of sales
|
54,002 | 75,528 | (21,526 | ) | -29 | % | ||||||||||
| 159,192 | 176,659 | (17,467 | ) | |||||||||||||
|
General and administrative expenses
|
1,763,758 | 1,318,213 | 445,545 | 34 | % | |||||||||||
|
Operating Loss
|
$ | (1,604,566 | ) | $ | (1,141,554 | ) | $ | (463,012 | ) | |||||||
|
June 30,
|
December 31,
|
$ | % | |||||||||||||
|
2013
|
2012
|
Change
|
Change
|
|||||||||||||
|
Cash
|
$ | 1,222 | $ | 5,523 | $ | (4,301 | ) | -78 | % | |||||||
|
Accounts payable and accured expenses
|
306,187 | 28,188 | (277,999 | ) | 986 | % | ||||||||||
| Total current Liabilities | 307,409 | 33,711 | 273,698 | 812 | % | |||||||||||
|
Cash proceeds from the sale of common stock
|
- | 12,000 | (12,000 | ) | -100 | % | ||||||||||
|
Cash proceeds from the sale of prefered stock
|
$ | 3,001 | $ | - | $ | 3,001 | 100 | % | ||||||||
|
●
|
Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company;
|
|
●
|
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.
|
|
Exhibit No.
|
Description
|
|
|
31.1
|
Certification of Chief Executive Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
31.2
|
Certification of Principal Financial Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.1
|
Certification of Chief Executive Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
32.2
|
Certification of Principal Financial Officer furnished pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
Dated: August 14, 2013
|
||
|
By
|
/s/ Dennis Cullison
|
|
|
Dennis Cullison
|
||
|
Chief Executive Officer, President and Director
|
||
|
Dated: August 14, 2013
|
||
|
By
|
/s/ Michael Tague
|
|
|
Michael Tague
|
||
|
Principle Financial Officer, Secretary and Director
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| The Scotts Miracle-Gro Company | SMG |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|